(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Koninklijke Philips, Xenetic Biosciences, and Nautilus.

The three biggest losers today are Sypris Solutions, SK Telecom, and Royalty Pharma.

Premarket Winners today

1. Koninklijke Philips (PHG) – Premarket: 11.61%

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

NYSE ended the session with Koninklijke Philips rising 2.56% to $19.03 on Monday while NYSE dropped 0.03% to $15,578.93.

Earnings Per Share

As for profitability, Koninklijke Philips has a trailing twelve months EPS of $-2.07.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.66%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Koninklijke Philips’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for Koninklijke Philips is 1331070 which is 26.44% below its average volume of 1809730.

Yearly Top and Bottom Value

Koninklijke Philips’s stock is valued at $19.03 at 08:34 EST, way below its 52-week high of $31.06 and way above its 52-week low of $11.75.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Koninklijke Philips’s EBITDA is 206.

More news about Koninklijke Philips.

2. Xenetic Biosciences (XBIO) – Premarket: 4.53%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences sliding 5.21% to $0.46 on Monday, after two successive sessions in a row of losses. NASDAQ jumped 0.11% to $12,072.46, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-0.51.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.9%.

Volume

Today’s last reported volume for Xenetic Biosciences is 27507 which is 44.72% below its average volume of 49767.

More news about Xenetic Biosciences.

3. Nautilus (NLS) – Premarket: 3.05%

Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer and commercial use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates in two segments, Direct and Retail. It offers specialized cardio products, treadmills, ellipticals, bike products, home gyms, dumbbells, barbells, and kettlebells primarily under the Nautilus, Bowflex, Octane Fitness, and Schwinn brands, as well as fitness digital platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.

NYSE ended the session with Nautilus sliding 1.5% to $1.31 on Monday while NYSE slid 0.03% to $15,578.93.

Earnings Per Share

As for profitability, Nautilus has a trailing twelve months EPS of $-3.29.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -79.46%.

More news about Nautilus.

4. Marathon (MARA) – Premarket: 2.13%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon dropping 6.25% to $8.93 on Monday, after three sequential sessions in a row of losses. NASDAQ rose 0.11% to $12,072.46, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-5.52.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -128.6%.

Volatility

Marathon’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.54%, a positive 0.80%, and a positive 6.80%.

Marathon’s highest amplitude of average volatility was 7.54% (last week), 6.86% (last month), and 6.80% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Marathon’s stock is valued at $8.93 at 08:34 EST, way under its 52-week high of $22.09 and way higher than its 52-week low of $3.11.

More news about Marathon.

5. Aurora Cannabis (ACB) – Premarket: 2.01%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis rising 1.62% to $0.62 on Monday while NYSE dropped 0.03% to $15,578.93.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-5.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -134.22%.

Moving Average

Aurora Cannabis’s worth is way under its 50-day moving average of $0.93 and way under its 200-day moving average of $1.27.

Volume

Today’s last reported volume for Aurora Cannabis is 695018 which is 86.48% below its average volume of 5141440.

Sales Growth

Aurora Cannabis’s sales growth is 29% for the present quarter and 28.1% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 18%, now sitting on 210.49M for the twelve trailing months.

More news about Aurora Cannabis.

6. Credit Suisse Group (CS) – Premarket: 1.56%

Credit Suisse Group AG, together with its subsidiaries, provides various financial services in Switzerland, Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company offers wealth management solutions, including investment advice and discretionary asset management services; risk management solutions, such as managed investment products; and wealth and succession planning. It also provides financing and lending solutions, including consumer credit and real estate mortgage lending, real asset lending relating to ship, and aviation financing for UHNWI; standard and structured hedging, and lombard lending solutions, as well as collateral trading services; and investment banking solutions, such as global securities sales, trading and execution, capital raising, and advisory services. In addition, the company offers banking solutions, such as payments, accounts, debit and credit cards, product bundles, and mortgages; asset management products; equity and debt capital markets, and advisory services; cash equities, equity derivatives, and convertibles, as well as prime services and fixed income products, such as credit, securitized, macro, emerging markets, financing, structured credit, and other products. Further, it provides HOLT, a framework for assessing the performance of approximately 20,000 companies; and equity and fixed income research services. The company serves private and institutional clients; ultra-high-net-worth individuals, high-net-worth individuals, and affluent and retail clients; corporate clients, small and medium-sized enterprises, external asset managers, financial institutions, and commodity traders; and pension funds, hedge funds, governments, foundations and endowments, corporations, entrepreneurs, private individuals, and financial sponsors. Credit Suisse Group AG was founded in 1856 and is based in Zurich, Switzerland.

NYSE ended the session with Credit Suisse Group falling 2.73% to $0.89 on Monday while NYSE fell 0.03% to $15,578.93.

Earnings Per Share

As for profitability, Credit Suisse Group has a trailing twelve months EPS of $-2.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.09%.

Volatility

Credit Suisse Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.85%, a positive 0.29%, and a positive 3.00%.

Credit Suisse Group’s highest amplitude of average volatility was 0.92% (last week), 1.73% (last month), and 3.00% (last quarter).

More news about Credit Suisse Group.

7. SNDL Inc. (SNDL) – Premarket: 1.39%

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

NASDAQ ended the session with SNDL Inc. falling 2.04% to $1.44 on Monday while NASDAQ jumped 0.11% to $12,072.46.

Earnings Per Share

As for profitability, SNDL Inc. has a trailing twelve months EPS of $-0.88.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.89%.

Volatility

SNDL Inc.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.92%, a negative 0.52%, and a positive 3.15%.

SNDL Inc.’s highest amplitude of average volatility was 2.92% (last week), 2.19% (last month), and 3.15% (last quarter).

More news about SNDL Inc..

8. Beyond Meat (BYND) – Premarket: 1.14%

Beyond Meat, Inc. develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club, convenience, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was founded in 2009 and is headquartered in El Segundo, California.

NASDAQ ended the session with Beyond Meat rising 1.15% to $14.09 on Monday while NASDAQ jumped 0.11% to $12,072.46.

Earnings Per Share

As for profitability, Beyond Meat has a trailing twelve months EPS of $-5.77.

More news about Beyond Meat.

9. SmileDirectClub (SDC) – Premarket: 0.98%

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.

NASDAQ ended the session with SmileDirectClub jumping 0.98% to $0.41 on Monday while NASDAQ rose 0.11% to $12,072.46.

Earnings Per Share

As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.

More news about SmileDirectClub.

10. Kosmos Energy (KOS) – Premarket: 0.87%

Kosmos Energy Ltd. engages in the exploration and production of oil and gas properties along the Atlantic Margins in the United States. The company's primary assets include production projects located in offshore Ghana, Equatorial Guinea, and the U.S. Gulf of Mexico, as well as a gas projects located in offshore Mauritania and Senegal. It also undertakes a proven basin exploration program in Equatorial Guinea and the U.S. Gulf of Mexico. Kosmos Energy Ltd. was founded in 2003 and is headquartered in Dallas, Texas.

NYSE ended the session with Kosmos Energy sliding 1.78% to $6.91 on Monday, after five sequential sessions in a row of losses. NYSE fell 0.03% to $15,578.93, after three consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Kosmos Energy has a trailing twelve months EPS of $0.47.

PE Ratio

Kosmos Energy has a trailing twelve months price to earnings ratio of 14.71. Meaning, the purchaser of the share is investing $14.71 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.4%.

Sales Growth

Kosmos Energy’s sales growth is negative 33.2% for the present quarter and negative 18.8% for the next.

Volume

Today’s last reported volume for Kosmos Energy is 1970170 which is 68.33% below its average volume of 6221630.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kosmos Energy’s EBITDA is -82.75.

More news about Kosmos Energy.

Premarket Losers Today

1. Sypris Solutions (SYPR) – Premarket: -4.19%

Sypris Solutions, Inc. engages in the provision of truck components, oil and gas pipeline components, and aerospace and defense electronics primarily in North America and Mexico. It operates in two segments, Sypris Technologies and Sypris Electronics. The Sypris Technologies segment supplies forged, machined, welded, and heat-treated steel components for the commercial vehicle, off highway vehicle, recreational vehicle, automotive, industrial, light truck, and energy markets. This segment also offers drive train components, including axle shafts, transmission shafts, gear sets, steer axle knuckles, and other components for automotive, truck, and recreational vehicle manufacturers. In addition, the segment provides value added operations for drive train assemblies; and manufactures pressurized closures, insulated joints, and other fabricated and specialty products for oil and gas pipelines and related energy markets. The Sypris Electronics segment offers electronic manufacturing services, such as circuit card and full box build manufacturing, high reliability manufacturing, systems assembly and integration, design for manufacturability, and design for specification work for aerospace and defense electronics markets. This segment also provides circuit card assembly services for electronic sensors and systems, including radar systems, tactical ground stations, navigation systems, weapons systems, and targeting and warning systems; and value-added solutions, such as low-volume prototype assembly and high-volume turnkey manufacturing. The company also offers engineering design and repair or inspection services. In addition, it sells its engineered product under the Tube Turns brand. The company was incorporated in 1997 and is headquartered in Louisville, Kentucky.

NASDAQ ended the session with Sypris Solutions sliding 0.25% to $2.15 on Monday, after three consecutive sessions in a row of losses. NASDAQ rose 0.11% to $12,072.46, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Sypris Solutions has a trailing twelve months EPS of $-0.11.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.84%.

Sales Growth

Sypris Solutions’s sales growth is 5.8% for the present quarter and negative 20% for the next.

Volume

Today’s last reported volume for Sypris Solutions is 1226 which is 94.82% below its average volume of 23675.

Moving Average

Sypris Solutions’s value is above its 50-day moving average of $2.02 and higher than its 200-day moving average of $2.03.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Sypris Solutions’s EBITDA is 69.03.

More news about Sypris Solutions.

2. SK Telecom (SKM) – Premarket: -2.25%

SK Telecom Co., Ltd. provides wireless telecommunication services in South Korea. The company operates through three segments: Cellular Services, Fixed-Line Telecommunications Services, and Other Businesses. The Cellular Services segment offers wireless voice and data transmission, Internet of Things solutions, platform, cloud, smart factory solutions, subscription, and metaverse platform-based services, as well as sells wireless devices. The Fixed-Line Telecommunications Services segment provides fixed-line telephone services; broadband Internet services; media platform services, such as Internet protocol TV and cable TV; and business communications services. The Other Businesses segment offers television shopping services under the T-commerce brand, as well as portal services. In addition, it provides call center management, base station maintenance, information gathering and consulting, system software development and supply, quantum information and communications, data base and internet website, and digital contents sourcing services; manufactures and sells e-book; sells contents and mastering quality sound album; sells and trades in anti-theft and surveillance devices; and operates information and communications facilities. SK Telecom Company Limited was incorporated in 1984 and is headquartered in Seoul, South Korea.

NYSE ended the session with SK Telecom falling 0.22% to $20.14 on Monday while NYSE fell 0.03% to $15,578.93.

Earnings Per Share

As for profitability, SK Telecom has a trailing twelve months EPS of $1.74.

PE Ratio

SK Telecom has a trailing twelve months price to earnings ratio of 11.57. Meaning, the purchaser of the share is investing $11.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.74%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Sep 28, 2022, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 8.75%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.2%, now sitting on 17.3T for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SK Telecom’s EBITDA is 0.01.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SK Telecom’s stock is considered to be overbought (>=80).

More news about SK Telecom.

3. Royalty Pharma (RPRX) – Premarket: -2.19%

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

NASDAQ ended the session with Royalty Pharma dropping 0.01% to $36.10 on Monday while NASDAQ rose 0.11% to $12,072.46.

Earnings Per Share

As for profitability, Royalty Pharma has a trailing twelve months EPS of $0.1.

PE Ratio

Royalty Pharma has a trailing twelve months price to earnings ratio of 361.05. Meaning, the purchaser of the share is investing $361.05 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.33%.

More news about Royalty Pharma.

4. GoPro (GPRO) – Premarket: -1.96%

GoPro, Inc. develops and sells cameras, mountable and wearable accessories, and subscription services and software in the Americas, Europe, the Middle East, Africa, the Asia and Pacific region, and internationally. The company provides cloud connected HERO11 Black, HERO11 Black Mini, HERO10 Black, HERO10 Black Bones, HERO9 Black, and HERO8 Black waterproof cameras; MAX, a 360-degree waterproof camera; GoPro, a subscription service that includes full access to the Quik app, cloud storage supporting source video and photo quality, camera replacement, and damage protection; Quik subscription offers access to editing tools, which allows users to edit photos, videos, and create cinematic stories; and Quik app, a mobile app that enable users to get their favorite photos and videos with footage from any phone or camera. It also offers mounts and accessories comprising equipment-based mounts consisting of helmet, handlebar, roll bar, and tripod mounts that enable consumers to wear the mount on their bodies, such as wrist housings, magnetic swivel clips, chest harnesses, and head straps; media, display, and light mods; spare batteries, dive filters, and charging accessories and cables; and lifestyle gears. In addition, the company provides mobile and web applications that provides media workflow for archiving, editing, multi-clip story creation, and sharing content on the fly. GoPro, Inc. markets and sells its products through retailers and wholesale distributors, as well as through its GoPro.com website. The company was formerly known as Woodman Labs, Inc. and changed its name to GoPro, Inc. in February 2014. GoPro, Inc. was founded in 2002 and is headquartered in San Mateo, California.

NASDAQ ended the session with GoPro dropping 0.41% to $4.51 on Monday, after four sequential sessions in a row of losses. NASDAQ jumped 0.11% to $12,072.46, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, GoPro has a trailing twelve months EPS of $0.18.

PE Ratio

GoPro has a trailing twelve months price to earnings ratio of 25.06. Meaning, the purchaser of the share is investing $25.06 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.7%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 17.9%, now sitting on 1.09B for the twelve trailing months.

More news about GoPro.

5. Pacific Biosciences of California (PACB) – Premarket: -1.91%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California rising 0.18% to $11.01 on Monday, following the last session’s upward trend. NASDAQ rose 0.11% to $12,072.46, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.41.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -46.42%.

Moving Average

Pacific Biosciences of California’s worth is way higher than its 50-day moving average of $9.90 and way above its 200-day moving average of $8.18.

More news about Pacific Biosciences of California.

6. FuboTV (FUBO) – Premarket: -1.72%

fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.

NYSE ended the session with FuboTV jumping 3.57% to $1.16 on Monday while NYSE fell 0.03% to $15,578.93.

Earnings Per Share

As for profitability, FuboTV has a trailing twelve months EPS of $-2.26.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.5%.

Volume

Today’s last reported volume for FuboTV is 6967340 which is 46.02% below its average volume of 12908000.

Yearly Top and Bottom Value

FuboTV’s stock is valued at $1.16 at 08:34 EST, way under its 52-week low of $1.35.

More news about FuboTV.

7. New York Times (NYT) – Premarket: -1.41%

The New York Times Company, together with its subsidiaries, provides news and information for readers and viewers across various platforms worldwide. It offers The New York Times (The Times), a daily and Sunday newspaper in the United States, as well as international edition of The Times; and operates the NYTimes.com website. The company also licenses articles, graphics, and photographs to newspapers, magazines and websites; and licenses content to digital aggregators in the business, professional, academic and library markets; third-party digital platforms; and for use in television, films and books. In addition, it engages in the live events business, which hosts events to connect audiences with journalists and outside thought leaders; and digital advertising business that includes direct-sold website, mobile application, podcast, email, and video advertisements. Further, the company offers The Athletic, a sports media product; Cooking, a recipe product; Games, a puzzle games product; and Audm, a read-aloud audio service that are available on mobile applications and websites, as well as Wirecutter, a product review and recommendation product. It also prints and distributes products for third parties; and offers other products and services. The company was founded in 1851 and is headquartered in New York, New York.

NYSE ended the session with New York Times jumping 0.58% to $39.85 on Monday while NYSE dropped 0.03% to $15,578.93.

Earnings Per Share

As for profitability, New York Times has a trailing twelve months EPS of $1.04.

PE Ratio

New York Times has a trailing twelve months price to earnings ratio of 38.32. Meaning, the purchaser of the share is investing $38.32 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.07%.

Volume

Today’s last reported volume for New York Times is 260361 which is 74.82% below its average volume of 1034270.

Volatility

New York Times’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.31%, a positive 0.42%, and a positive 1.32%.

New York Times’s highest amplitude of average volatility was 0.65% (last week), 0.85% (last month), and 1.32% (last quarter).

Yearly Top and Bottom Value

New York Times’s stock is valued at $39.85 at 08:34 EST, way below its 52-week high of $44.49 and way higher than its 52-week low of $27.59.

More news about New York Times.

8. Geo Group (GEO) – Premarket: -1.15%

The GEO Group, Inc. engages in the ownership, leasing, and management of secure facilities, reentry facilities, and processing centers in the United States, Australia, and South Africa. It operates through four segments: U.S. Secure Services, Electronic Monitoring and Supervision Services, Reentry Services, and International Services. The company provides counseling, education, and treatment for alcohol and drug abuse problems at various facilities; and compliance technologies for monitoring services, and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants. It also offers secure facility management services, including security, administrative, rehabilitation, education, and food services at secure services facilities; reentry services comprising supervision of individuals in community-based programs and reentry centers, and provision of temporary housing, programming, employment assistance, and other services; and supervision and reporting services that improves the participation of non-detained aliens in the immigration court system. In addition, the company provides secure transportation services; and rehabilitation services, such as evidence-based, including cognitive behavioral treatment and post-release services, as well as academic and vocational classes in life skills and treatment programs under the GEO Continuum of Care platform; and develops new facilities based on contract, as well as designs, constructs, and finances the facilities. The GEO Group, Inc. was founded in 1984 and is headquartered in Boca Raton, Florida.

NYSE ended the session with Geo Group dropping 1.13% to $7.84 on Monday while NYSE fell 0.03% to $15,578.93.

Earnings Per Share

As for profitability, Geo Group has a trailing twelve months EPS of $1.18.

PE Ratio

Geo Group has a trailing twelve months price to earnings ratio of 6.64. Meaning, the purchaser of the share is investing $6.64 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.04%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Geo Group’s EBITDA is 23.92.

More news about Geo Group.

9. ZoomInfo (ZI) – Premarket: -1.14%

ZoomInfo Technologies Inc., through its subsidiaries, provides go-to-market intelligence and engagement platform for sales and marketing teams in the United States and internationally. The company's cloud-based platform provides information on organizations and professionals to help users identify target customers and decision makers, obtain continually updated predictive lead and company scoring, monitor buying signals and other attributes of target companies, craft messages, engage through automated sales tools, and track progress through the deal cycle. It serves enterprises, mid-market companies, and down to small businesses that operate in various industry verticals, including software, business services, manufacturing, telecommunications, financial services, retail, media and internet, transportation, education, hospitality, and real estate. ZoomInfo Technologies Inc. was founded in 2007 and is headquartered in Vancouver, Washington.

NASDAQ ended the session with ZoomInfo jumping 2.45% to $21.99 on Monday, following the last session’s upward trend. NASDAQ rose 0.11% to $12,072.46, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, ZoomInfo has a trailing twelve months EPS of $0.16.

PE Ratio

ZoomInfo has a trailing twelve months price to earnings ratio of 137.41. Meaning, the purchaser of the share is investing $137.41 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.96%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 22.2% and 9.5%, respectively.

More news about ZoomInfo.

10. Arcelor Mittal (MT) – Premarket: -1.05%

ArcelorMittal S.A., together with its subsidiaries, operates as integrated steel and mining companies in the Americas, Europe, Asia, and Africa. It offers semi-finished flat products, including slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, tinplate, and color coated coils and sheets; semi-finished long products, such as blooms and billets; finished long products consisting of bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company also provides mining products, such as iron ore lumps, fines, concentrates, pellets, and sinter feeds; and coking and pulverized coal injections coal. It sells its products to various customers in the automotive, appliance, engineering, construction, energy, and machinery industries through a centralized marketing organization, as well as distributors. The company has iron ore mining activities in Brazil, Bosnia, Canada, Kazakhstan, Liberia, Mexico, South Africa, and Ukraine; and coal mining activities in Kazakhstan. ArcelorMittal S.A. was founded in 1976 and is headquartered in Luxembourg City, Luxembourg.

NYSE ended the session with Arcelor Mittal falling 2.87% to $28.46 on Monday while NYSE dropped 0.03% to $15,578.93.

Earnings Per Share

As for profitability, Arcelor Mittal has a trailing twelve months EPS of $10.18.

PE Ratio

Arcelor Mittal has a trailing twelve months price to earnings ratio of 2.8. Meaning, the purchaser of the share is investing $2.8 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.84%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 18.8%, now sitting on 79.84B for the twelve trailing months.

More news about Arcelor Mittal.

Stay up to date with our premarket winners and losers daily report